pubmed.ncbi.nlm.nih.gov

Botanicals in dermatology: an evidence-based review - PubMed

Review

Botanicals in dermatology: an evidence-based review

Juliane Reuter et al. Am J Clin Dermatol. 2010.

Abstract

Botanical extracts and single compounds are increasingly used in cosmetics but also in over-the-counter drugs and food supplements. The focus of the present review is on controlled clinical trials with botanicals in the treatment of acne, inflammatory skin diseases, skin infections, UV-induced skin damage, skin cancer, alopecia, vitiligo, and wounds. Studies with botanical cosmetics and drugs are discussed, as well as studies with botanical food supplements. Experimental research on botanicals was considered to a limited extent when it seemed promising for clinical use in the near future. In acne therapy, Mahonia, tea tree oil, and Saccharomyces may have the potential to become standard treatments. Mahonia, Hypericum, Glycyrrhiza and some traditional Chinese medicines appear promising for atopic dermatitis. Some plant-derived substances like dithranol and methoxsalen (8-methoxypsoralen) [in combination with UVA] are already accepted as standard treatments in psoriasis; Mahonia and Capsicum (capsaicin) are the next candidates suggested by present evidence. Oral administration and topical application of antioxidant plant extracts (green and black tea, carotenoids, coffee, and many flavonoids from fruits and vegetables) can protect skin from UV-induced erythema, early aging, and irradiation-induced cancer. Hair loss and vitiligo are also traditional fields of application for botanicals. According to the number and quality of clinical trials with botanicals, the best evidence exists for the treatment of inflammatory skin diseases, i.e. atopic dermatitis and psoriasis. However, many more controlled clinical studies are needed to determine the efficacy and risks of plant-derived products in dermatology. Safety aspects, especially related to sensitization and photodermatitis, have to be taken into account. Therefore, clinicians should not only be informed of the beneficial effects but also the specific adverse effects of botanicals used for dermatologic disorders and cosmetic purposes.

PubMed Disclaimer

Cited by

Naringenin ameliorates atopic dermatitis by inhibiting inflammation and enhancing immunity through the JAK2/STAT3 pathway.
Tian L, Wang M, Wang Y, Li W, Yang Y. Tian L, et al. Genes Genomics. 2024 Mar;46(3):333-340. doi: 10.1007/s13258-023-01457-8. Epub 2023 Oct 14. Genes Genomics. 2024. PMID: 37837514
Oral herbal medicines for psoriasis: a review of clinical studies.
May BH, Zhang AL, Zhou W, Lu CJ, Deng S, Xue CC. May BH, et al. Chin J Integr Med. 2012 Mar;18(3):172-8. doi: 10.1007/s11655-012-1008-z. Epub 2012 Apr 2. Chin J Integr Med. 2012. PMID: 22466940 Review.
Polyphenols from Mediterranean Plants: Biological Activities for Skin Photoprotection in Atopic Dermatitis, Psoriasis, and Chronic Urticaria.
Di Salvo E, Gangemi S, Genovese C, Cicero N, Casciaro M. Di Salvo E, et al. Plants (Basel). 2023 Oct 15;12(20):3579. doi: 10.3390/plants12203579. Plants (Basel). 2023. PMID: 37896042 Free PMC article. Review.
Luteolin inhibits human keratinocyte activation and decreases NF-κB induction that is increased in psoriatic skin.
Weng Z, Patel AB, Vasiadi M, Therianou A, Theoharides TC. Weng Z, et al. PLoS One. 2014 Feb 28;9(2):e90739. doi: 10.1371/journal.pone.0090739. eCollection 2014. PLoS One. 2014. PMID: 24587411 Free PMC article.
Luteolin-7-O-β-d-Glucoside Inhibits Cellular Energy Production Interacting with HEK2 in Keratinocytes.
Palombo R, Caporali S, Falconi M, Iacovelli F, Morozzo Della Rocca B, Lo Surdo A, Campione E, Candi E, Melino G, Bernardini S, Terrinoni A. Palombo R, et al. Int J Mol Sci. 2019 May 31;20(11):2689. doi: 10.3390/ijms20112689. Int J Mol Sci. 2019. PMID: 31159225 Free PMC article.

Botanicals in dermatology: an evidence-based review - PubMed